Follow Us
  • Facebook Basic Black
  • Twitter Basic Black
  • LinkedIn Social Icon

"SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?"

"New glucose-lowering agents for type 2 diabetes are expensive compared with older drugs, so it is important for patients, those treating them, and payers that information used to guide treatment decisions is based on a clear analysis of the benefits and risks of each drug."

Click here to read the full article


#SGLT2 #cardiology #Type2diabetes #news

Must Read